ETON
Eton Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$14.76
+0.41 (+2.86%)
Open$14.60
Previous Close$14.35
Day High$15.01
Day Low$14.52
52W High$23.00
52W Low$11.09
Volume—
Avg Volume207.0K
Market Cap395.83M
P/E Ratio—
EPS$-0.25
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
-19.2% upside
Current
$14.76
$14.76
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 40.40M | 33.29M | 123.87M |
| Net Income | -3,958,268 | -2,935,674 | 16.69M |
| Profit Margin | -9.8% | -9.3% | 13.5% |
| EBITDA | -1,501,782 | -1,175,684 | 22.30M |
| Free Cash Flow | — | — | 13.57M |
| Rev Growth | +21.4% | +21.4% | -9.3% |
| Debt/Equity | 1.22 | 1.22 | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |